ReviewPharmacy (Basel, Switzerland)2019
An Integrated Health-System Specialty Pharmacy Model for Coordinating Transitions of Care: Specialty Medication Challenges and Specialty Pharmacist Opportunities.
Review in Pharmacy (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Patient-Tailored Interventions to Improve Specialty Medication Adherence: Results from a Prospective Randomized Controlled Trial.The American journal of medicine · 2023Trial
- Comparing rates of primary medication nonadherence and turnaround time among patients at a health system specialty pharmacy compared with external specialty pharmacies.Journal of managed care & specialty pharmacy · 2026Article
- Finding consensus on meaningful reporting measures for rheumatoid arthritis: Results from a modified Delphi study.Journal of managed care & specialty pharmacy · 2026Article
- Improving chronic myeloid leukemia management and quality of life: patient and physician survey on unmet needs from the CML SUN survey.Haematologica · 2026Article
- Racial and Socioeconomic Differences in Real-World Use of Biologic Therapy for Asthma.Journal of asthma and allergy · 2026Article
- Capturing Value: How Health-System Specialty Pharmacies Define and Document Pharmacist Interventions.Pharmacy (Basel, Switzerland) · 2025Article
- Ustekinumab infusion to subcutaneous transition: Coordinating care and identifying potential gaps.Journal of managed care & specialty pharmacy · 2025Article
- Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024Review
- Review
- Comparison of time to treatment initiation of specialty medications between an integrated health system specialty pharmacy and external specialty pharmacies.Journal of managed care & specialty pharmacy · 2024Article
- Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease.Digestive diseases and sciences · 2023Article
- Specialty pharmacy turnaround time impediments, facilitators, and good practices.Journal of managed care & specialty pharmacy · 2022Article
- Pharmacist-managed multistep order transmittal for electronic specialty prescriptions reduces represcribing burden in ambulatory clinics: A retrospective cohort pilot study.Journal of managed care & specialty pharmacy · 2022Article
- Association between health system specialty pharmacy use and health care costs among national sample of Medicare Advantage beneficiaries.Journal of managed care & specialty pharmacy · 2022Article
- Exploring healthcare providers' experiences with specialty medication and limited distribution networks.PloS one · 2022Article
- Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics.Pharmacy (Basel, Switzerland) · 2021Review
- Development, implementation, and evaluation of a health outcomes and research program at an integrated health-system specialty pharmacy.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2021Article
- Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy.Journal of managed care & specialty pharmacy · 2021Observational
- Re-Engineering Collaborative Practice in Primary Care: Integrating Community Pharmacy to the Clinic; Creating a Pharmacy Referral and Quality Circle.Innovations in pharmacy · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adherence and persistence to specialty medications are necessary to achieve successful outcomes of costly therapies. The increasing use of specialty medications has exposed several unique barriers to certain specialty treatments' continuation. Integrated specialty pharmacy teams facilitate transitions in sites of care, between different provider types, among prescribed specialty medications, and during financial coverage changes. We review obstacles encountered within these types of transitions and the role of the specialty pharmacist in overcoming these obstacles. Case examples for each type of specialty transition provide insight into the unique complexities faced by patients, and shed light on pharmacists' vital role in patient care. This insightful and real-world experience is needed to facilitate best practices in specialty care, particularly in the growing number of health-system specialty pharmacies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.